nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—GNRHR—Peptide GPCRs—CXCR1—ulcerative colitis	0.00552	0.0918	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—CXCR1—ulcerative colitis	0.00468	0.0778	CbGpPWpGaD
Nafarelin—Desmopressin—PTGS1—ulcerative colitis	0.00442	0.636	CrCbGaD
Nafarelin—GNRHR—Peptide GPCRs—CXCR2—ulcerative colitis	0.00432	0.0719	CbGpPWpGaD
Nafarelin—GNRHR—Peptide GPCRs—CCR6—ulcerative colitis	0.00406	0.0676	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—CXCR2—ulcerative colitis	0.00366	0.0609	CbGpPWpGaD
Nafarelin—Desmopressin—PTGS2—ulcerative colitis	0.00253	0.364	CrCbGaD
Nafarelin—GNRHR—GPCRs, Other—ADRB2—ulcerative colitis	0.0023	0.0382	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00174	0.029	CbGpPWpGaD
Nafarelin—Increased appetite—Prednisone—ulcerative colitis	0.00161	0.00173	CcSEcCtD
Nafarelin—Myalgia—Azathioprine—ulcerative colitis	0.00161	0.00173	CcSEcCtD
Nafarelin—Arthralgia—Azathioprine—ulcerative colitis	0.00161	0.00173	CcSEcCtD
Nafarelin—Sweating increased—Methylprednisolone—ulcerative colitis	0.00161	0.00173	CcSEcCtD
Nafarelin—Weight increased—Hydrocortisone—ulcerative colitis	0.0016	0.00172	CcSEcCtD
Nafarelin—Vomiting—Nicotine—ulcerative colitis	0.0016	0.00171	CcSEcCtD
Nafarelin—Dry skin—Dexamethasone—ulcerative colitis	0.00159	0.00171	CcSEcCtD
Nafarelin—Dry skin—Betamethasone—ulcerative colitis	0.00159	0.00171	CcSEcCtD
Nafarelin—Weight decreased—Hydrocortisone—ulcerative colitis	0.00159	0.00171	CcSEcCtD
Nafarelin—Rash—Nicotine—ulcerative colitis	0.00158	0.0017	CcSEcCtD
Nafarelin—Acute coronary syndrome—Prednisolone—ulcerative colitis	0.00158	0.0017	CcSEcCtD
Nafarelin—Dermatitis—Nicotine—ulcerative colitis	0.00158	0.0017	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Budesonide—ulcerative colitis	0.00158	0.00169	CcSEcCtD
Nafarelin—Myocardial infarction—Prednisolone—ulcerative colitis	0.00157	0.00169	CcSEcCtD
Nafarelin—Headache—Nicotine—ulcerative colitis	0.00157	0.00169	CcSEcCtD
Nafarelin—Insomnia—Budesonide—ulcerative colitis	0.00156	0.00168	CcSEcCtD
Nafarelin—Conjunctivitis—Prednisolone—ulcerative colitis	0.00156	0.00167	CcSEcCtD
Nafarelin—GNRHR—G alpha (q) signalling events—GHRL—ulcerative colitis	0.00156	0.0259	CbGpPWpGaD
Nafarelin—Paraesthesia—Budesonide—ulcerative colitis	0.00155	0.00166	CcSEcCtD
Nafarelin—Vertigo—Mesalazine—ulcerative colitis	0.00155	0.00166	CcSEcCtD
Nafarelin—Acute coronary syndrome—Hydrocortisone—ulcerative colitis	0.00155	0.00166	CcSEcCtD
Nafarelin—Dyspnoea—Budesonide—ulcerative colitis	0.00154	0.00165	CcSEcCtD
Nafarelin—Nausea—Mercaptopurine—ulcerative colitis	0.00154	0.00165	CcSEcCtD
Nafarelin—Myocardial infarction—Hydrocortisone—ulcerative colitis	0.00154	0.00165	CcSEcCtD
Nafarelin—Muscular weakness—Betamethasone—ulcerative colitis	0.00153	0.00164	CcSEcCtD
Nafarelin—Muscular weakness—Dexamethasone—ulcerative colitis	0.00153	0.00164	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00153	0.0254	CbGpPWpGaD
Nafarelin—Palpitations—Mesalazine—ulcerative colitis	0.00152	0.00163	CcSEcCtD
Nafarelin—Weight increased—Triamcinolone—ulcerative colitis	0.00151	0.00162	CcSEcCtD
Nafarelin—Weight increased—Methylprednisolone—ulcerative colitis	0.0015	0.00161	CcSEcCtD
Nafarelin—Decreased appetite—Budesonide—ulcerative colitis	0.0015	0.00161	CcSEcCtD
Nafarelin—Nausea—Nicotine—ulcerative colitis	0.00149	0.0016	CcSEcCtD
Nafarelin—Affect lability—Prednisone—ulcerative colitis	0.00149	0.0016	CcSEcCtD
Nafarelin—Constipation—Budesonide—ulcerative colitis	0.00148	0.00159	CcSEcCtD
Nafarelin—Myalgia—Mesalazine—ulcerative colitis	0.00147	0.00157	CcSEcCtD
Nafarelin—Chest pain—Mesalazine—ulcerative colitis	0.00147	0.00157	CcSEcCtD
Nafarelin—Arthralgia—Mesalazine—ulcerative colitis	0.00147	0.00157	CcSEcCtD
Nafarelin—Sweating increased—Dexamethasone—ulcerative colitis	0.00146	0.00157	CcSEcCtD
Nafarelin—Sweating increased—Betamethasone—ulcerative colitis	0.00146	0.00157	CcSEcCtD
Nafarelin—Acute coronary syndrome—Triamcinolone—ulcerative colitis	0.00146	0.00156	CcSEcCtD
Nafarelin—Acute coronary syndrome—Methylprednisolone—ulcerative colitis	0.00145	0.00156	CcSEcCtD
Nafarelin—Myocardial infarction—Triamcinolone—ulcerative colitis	0.00145	0.00155	CcSEcCtD
Nafarelin—Myocardial infarction—Methylprednisolone—ulcerative colitis	0.00144	0.00155	CcSEcCtD
Nafarelin—Conjunctivitis—Triamcinolone—ulcerative colitis	0.00144	0.00154	CcSEcCtD
Nafarelin—Mood swings—Prednisone—ulcerative colitis	0.00143	0.00154	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.00141	0.00151	CcSEcCtD
Nafarelin—Oedema—Mesalazine—ulcerative colitis	0.00141	0.00151	CcSEcCtD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.00139	0.0232	CbGpPWpGaD
Nafarelin—Epistaxis—Triamcinolone—ulcerative colitis	0.00139	0.00149	CcSEcCtD
Nafarelin—Dry skin—Prednisone—ulcerative colitis	0.00139	0.00149	CcSEcCtD
Nafarelin—Shock—Mesalazine—ulcerative colitis	0.00138	0.00148	CcSEcCtD
Nafarelin—Urticaria—Budesonide—ulcerative colitis	0.00137	0.00147	CcSEcCtD
Nafarelin—Weight increased—Dexamethasone—ulcerative colitis	0.00137	0.00147	CcSEcCtD
Nafarelin—Weight increased—Betamethasone—ulcerative colitis	0.00137	0.00147	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00136	0.0227	CbGpPWpGaD
Nafarelin—Hyperhidrosis—Mesalazine—ulcerative colitis	0.00136	0.00146	CcSEcCtD
Nafarelin—Weight decreased—Dexamethasone—ulcerative colitis	0.00136	0.00146	CcSEcCtD
Nafarelin—Weight decreased—Betamethasone—ulcerative colitis	0.00136	0.00146	CcSEcCtD
Nafarelin—Anorexia—Mesalazine—ulcerative colitis	0.00134	0.00144	CcSEcCtD
Nafarelin—Muscular weakness—Prednisone—ulcerative colitis	0.00134	0.00143	CcSEcCtD
Nafarelin—Rhinitis—Triamcinolone—ulcerative colitis	0.00133	0.00142	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CXCR1—ulcerative colitis	0.00133	0.0221	CbGpPWpGaD
Nafarelin—Rhinitis—Methylprednisolone—ulcerative colitis	0.00133	0.00142	CcSEcCtD
Nafarelin—Acute coronary syndrome—Betamethasone—ulcerative colitis	0.00132	0.00142	CcSEcCtD
Nafarelin—Acute coronary syndrome—Dexamethasone—ulcerative colitis	0.00132	0.00142	CcSEcCtD
Nafarelin—Abdominal distension—Prednisone—ulcerative colitis	0.00132	0.00141	CcSEcCtD
Nafarelin—Myocardial infarction—Dexamethasone—ulcerative colitis	0.00131	0.00141	CcSEcCtD
Nafarelin—Myocardial infarction—Betamethasone—ulcerative colitis	0.00131	0.00141	CcSEcCtD
Nafarelin—Conjunctivitis—Dexamethasone—ulcerative colitis	0.0013	0.0014	CcSEcCtD
Nafarelin—Conjunctivitis—Betamethasone—ulcerative colitis	0.0013	0.0014	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.00128	0.00137	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00128	0.0213	CbGpPWpGaD
Nafarelin—Sweating increased—Prednisone—ulcerative colitis	0.00127	0.00137	CcSEcCtD
Nafarelin—Insomnia—Mesalazine—ulcerative colitis	0.00127	0.00136	CcSEcCtD
Nafarelin—Paraesthesia—Mesalazine—ulcerative colitis	0.00126	0.00135	CcSEcCtD
Nafarelin—Dyspnoea—Mesalazine—ulcerative colitis	0.00125	0.00134	CcSEcCtD
Nafarelin—Asthenia—Budesonide—ulcerative colitis	0.00124	0.00133	CcSEcCtD
Nafarelin—Mental disorder—Hydrocortisone—ulcerative colitis	0.00123	0.00132	CcSEcCtD
Nafarelin—Malnutrition—Hydrocortisone—ulcerative colitis	0.00123	0.00131	CcSEcCtD
Nafarelin—Pruritus—Budesonide—ulcerative colitis	0.00122	0.00131	CcSEcCtD
Nafarelin—Decreased appetite—Mesalazine—ulcerative colitis	0.00122	0.00131	CcSEcCtD
Nafarelin—Constipation—Mesalazine—ulcerative colitis	0.0012	0.00129	CcSEcCtD
Nafarelin—Weight increased—Prednisone—ulcerative colitis	0.00119	0.00128	CcSEcCtD
Nafarelin—Weight decreased—Prednisone—ulcerative colitis	0.00118	0.00127	CcSEcCtD
Nafarelin—Diarrhoea—Budesonide—ulcerative colitis	0.00118	0.00127	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CCL20—ulcerative colitis	0.00116	0.0194	CbGpPWpGaD
Nafarelin—Depression—Prednisone—ulcerative colitis	0.00116	0.00125	CcSEcCtD
Nafarelin—Mental disorder—Methylprednisolone—ulcerative colitis	0.00116	0.00124	CcSEcCtD
Nafarelin—Malnutrition—Methylprednisolone—ulcerative colitis	0.00115	0.00123	CcSEcCtD
Nafarelin—Acute coronary syndrome—Prednisone—ulcerative colitis	0.00115	0.00123	CcSEcCtD
Nafarelin—Myocardial infarction—Prednisone—ulcerative colitis	0.00114	0.00123	CcSEcCtD
Nafarelin—Dizziness—Budesonide—ulcerative colitis	0.00114	0.00123	CcSEcCtD
Nafarelin—Dysgeusia—Triamcinolone—ulcerative colitis	0.00113	0.00121	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00113	0.0188	CbGpPWpGaD
Nafarelin—Vertigo—Prednisolone—ulcerative colitis	0.00113	0.00121	CcSEcCtD
Nafarelin—Urticaria—Mesalazine—ulcerative colitis	0.00112	0.0012	CcSEcCtD
Nafarelin—Vertigo—Hydrocortisone—ulcerative colitis	0.0011	0.00118	CcSEcCtD
Nafarelin—Vomiting—Budesonide—ulcerative colitis	0.0011	0.00118	CcSEcCtD
Nafarelin—Rash—Budesonide—ulcerative colitis	0.00109	0.00117	CcSEcCtD
Nafarelin—Dermatitis—Budesonide—ulcerative colitis	0.00109	0.00117	CcSEcCtD
Nafarelin—Convulsion—Prednisolone—ulcerative colitis	0.00109	0.00117	CcSEcCtD
Nafarelin—Headache—Budesonide—ulcerative colitis	0.00108	0.00116	CcSEcCtD
Nafarelin—Alopecia—Dexamethasone—ulcerative colitis	0.00106	0.00114	CcSEcCtD
Nafarelin—Alopecia—Betamethasone—ulcerative colitis	0.00106	0.00114	CcSEcCtD
Nafarelin—Convulsion—Hydrocortisone—ulcerative colitis	0.00106	0.00114	CcSEcCtD
Nafarelin—Diarrhoea—Azathioprine—ulcerative colitis	0.00106	0.00113	CcSEcCtD
Nafarelin—Myalgia—Hydrocortisone—ulcerative colitis	0.00104	0.00112	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CXCR2—ulcerative colitis	0.00104	0.0173	CbGpPWpGaD
Nafarelin—Vertigo—Triamcinolone—ulcerative colitis	0.00104	0.00111	CcSEcCtD
Nafarelin—Vertigo—Methylprednisolone—ulcerative colitis	0.00103	0.00111	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00103	0.0172	CbGpPWpGaD
Nafarelin—Nausea—Budesonide—ulcerative colitis	0.00103	0.0011	CcSEcCtD
Nafarelin—Oedema—Prednisolone—ulcerative colitis	0.00102	0.0011	CcSEcCtD
Nafarelin—Dizziness—Azathioprine—ulcerative colitis	0.00102	0.00109	CcSEcCtD
Nafarelin—Asthenia—Mesalazine—ulcerative colitis	0.00101	0.00108	CcSEcCtD
Nafarelin—Shock—Prednisolone—ulcerative colitis	0.00101	0.00108	CcSEcCtD
Nafarelin—Oedema—Hydrocortisone—ulcerative colitis	0.001	0.00107	CcSEcCtD
Nafarelin—Convulsion—Triamcinolone—ulcerative colitis	0.001	0.00107	CcSEcCtD
Nafarelin—Convulsion—Methylprednisolone—ulcerative colitis	0.000998	0.00107	CcSEcCtD
Nafarelin—Pruritus—Mesalazine—ulcerative colitis	0.000995	0.00107	CcSEcCtD
Nafarelin—Hyperhidrosis—Prednisolone—ulcerative colitis	0.00099	0.00106	CcSEcCtD
Nafarelin—Shock—Hydrocortisone—ulcerative colitis	0.000984	0.00105	CcSEcCtD
Nafarelin—Myalgia—Triamcinolone—ulcerative colitis	0.000982	0.00105	CcSEcCtD
Nafarelin—Vomiting—Azathioprine—ulcerative colitis	0.000982	0.00105	CcSEcCtD
Nafarelin—Myalgia—Methylprednisolone—ulcerative colitis	0.00098	0.00105	CcSEcCtD
Nafarelin—Arthralgia—Methylprednisolone—ulcerative colitis	0.00098	0.00105	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CCR6—ulcerative colitis	0.000976	0.0162	CbGpPWpGaD
Nafarelin—Rash—Azathioprine—ulcerative colitis	0.000974	0.00104	CcSEcCtD
Nafarelin—Dermatitis—Azathioprine—ulcerative colitis	0.000973	0.00104	CcSEcCtD
Nafarelin—Headache—Azathioprine—ulcerative colitis	0.000967	0.00104	CcSEcCtD
Nafarelin—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000967	0.00104	CcSEcCtD
Nafarelin—Diarrhoea—Mesalazine—ulcerative colitis	0.000962	0.00103	CcSEcCtD
Nafarelin—Anorexia—Hydrocortisone—ulcerative colitis	0.000953	0.00102	CcSEcCtD
Nafarelin—Oedema—Triamcinolone—ulcerative colitis	0.000942	0.00101	CcSEcCtD
Nafarelin—Vertigo—Dexamethasone—ulcerative colitis	0.000941	0.00101	CcSEcCtD
Nafarelin—Vertigo—Betamethasone—ulcerative colitis	0.000941	0.00101	CcSEcCtD
Nafarelin—Dizziness—Mesalazine—ulcerative colitis	0.00093	0.000997	CcSEcCtD
Nafarelin—Shock—Triamcinolone—ulcerative colitis	0.000926	0.000993	CcSEcCtD
Nafarelin—Insomnia—Prednisolone—ulcerative colitis	0.000926	0.000993	CcSEcCtD
Nafarelin—Alopecia—Prednisone—ulcerative colitis	0.000926	0.000992	CcSEcCtD
Nafarelin—Shock—Methylprednisolone—ulcerative colitis	0.000924	0.000991	CcSEcCtD
Nafarelin—Paraesthesia—Prednisolone—ulcerative colitis	0.00092	0.000986	CcSEcCtD
Nafarelin—Mental disorder—Prednisone—ulcerative colitis	0.000918	0.000984	CcSEcCtD
Nafarelin—Nausea—Azathioprine—ulcerative colitis	0.000917	0.000983	CcSEcCtD
Nafarelin—Malnutrition—Prednisone—ulcerative colitis	0.000912	0.000977	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000911	0.000977	CcSEcCtD
Nafarelin—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.00091	0.000976	CcSEcCtD
Nafarelin—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000908	0.000974	CcSEcCtD
Nafarelin—Convulsion—Betamethasone—ulcerative colitis	0.000907	0.000972	CcSEcCtD
Nafarelin—Convulsion—Dexamethasone—ulcerative colitis	0.000907	0.000972	CcSEcCtD
Nafarelin—Insomnia—Hydrocortisone—ulcerative colitis	0.000905	0.00097	CcSEcCtD
Nafarelin—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000898	0.000963	CcSEcCtD
Nafarelin—Vomiting—Mesalazine—ulcerative colitis	0.000894	0.000959	CcSEcCtD
Nafarelin—Myalgia—Dexamethasone—ulcerative colitis	0.000891	0.000955	CcSEcCtD
Nafarelin—Myalgia—Betamethasone—ulcerative colitis	0.000891	0.000955	CcSEcCtD
Nafarelin—Rash—Mesalazine—ulcerative colitis	0.000887	0.000951	CcSEcCtD
Nafarelin—Dermatitis—Mesalazine—ulcerative colitis	0.000886	0.00095	CcSEcCtD
Nafarelin—Headache—Mesalazine—ulcerative colitis	0.000881	0.000944	CcSEcCtD
Nafarelin—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000869	0.000932	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—PTGER4—ulcerative colitis	0.000859	0.0143	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000858	0.00092	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000856	0.000918	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000855	0.0142	CbGpPWpGaD
Nafarelin—Oedema—Betamethasone—ulcerative colitis	0.000854	0.000916	CcSEcCtD
Nafarelin—Oedema—Dexamethasone—ulcerative colitis	0.000854	0.000916	CcSEcCtD
Nafarelin—Insomnia—Triamcinolone—ulcerative colitis	0.000852	0.000913	CcSEcCtD
Nafarelin—Insomnia—Methylprednisolone—ulcerative colitis	0.00085	0.000911	CcSEcCtD
Nafarelin—Paraesthesia—Triamcinolone—ulcerative colitis	0.000846	0.000906	CcSEcCtD
Nafarelin—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000844	0.000904	CcSEcCtD
Nafarelin—Shock—Betamethasone—ulcerative colitis	0.000841	0.000901	CcSEcCtD
Nafarelin—Shock—Dexamethasone—ulcerative colitis	0.000841	0.000901	CcSEcCtD
Nafarelin—Dyspnoea—Triamcinolone—ulcerative colitis	0.00084	0.0009	CcSEcCtD
Nafarelin—Nausea—Mesalazine—ulcerative colitis	0.000835	0.000895	CcSEcCtD
Nafarelin—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000826	0.000885	CcSEcCtD
Nafarelin—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000826	0.000885	CcSEcCtD
Nafarelin—Vertigo—Prednisone—ulcerative colitis	0.000819	0.000878	CcSEcCtD
Nafarelin—Anorexia—Dexamethasone—ulcerative colitis	0.000814	0.000873	CcSEcCtD
Nafarelin—Anorexia—Betamethasone—ulcerative colitis	0.000814	0.000873	CcSEcCtD
Nafarelin—Urticaria—Prednisolone—ulcerative colitis	0.000814	0.000872	CcSEcCtD
Nafarelin—Urticaria—Hydrocortisone—ulcerative colitis	0.000795	0.000852	CcSEcCtD
Nafarelin—Convulsion—Prednisone—ulcerative colitis	0.00079	0.000847	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—GHRL—ulcerative colitis	0.000786	0.0131	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000778	0.000834	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000778	0.000834	CcSEcCtD
Nafarelin—Arthralgia—Prednisone—ulcerative colitis	0.000776	0.000832	CcSEcCtD
Nafarelin—Myalgia—Prednisone—ulcerative colitis	0.000776	0.000832	CcSEcCtD
Nafarelin—Insomnia—Dexamethasone—ulcerative colitis	0.000773	0.000828	CcSEcCtD
Nafarelin—Insomnia—Betamethasone—ulcerative colitis	0.000773	0.000828	CcSEcCtD
Nafarelin—Paraesthesia—Betamethasone—ulcerative colitis	0.000767	0.000822	CcSEcCtD
Nafarelin—Paraesthesia—Dexamethasone—ulcerative colitis	0.000767	0.000822	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000749	0.0125	CbGpPWpGaD
Nafarelin—Urticaria—Triamcinolone—ulcerative colitis	0.000748	0.000802	CcSEcCtD
Nafarelin—Urticaria—Methylprednisolone—ulcerative colitis	0.000746	0.0008	CcSEcCtD
Nafarelin—Oedema—Prednisone—ulcerative colitis	0.000744	0.000798	CcSEcCtD
Nafarelin—Decreased appetite—Dexamethasone—ulcerative colitis	0.000743	0.000796	CcSEcCtD
Nafarelin—Decreased appetite—Betamethasone—ulcerative colitis	0.000743	0.000796	CcSEcCtD
Nafarelin—Shock—Prednisone—ulcerative colitis	0.000732	0.000785	CcSEcCtD
Nafarelin—Hyperhidrosis—Prednisone—ulcerative colitis	0.000719	0.000771	CcSEcCtD
Nafarelin—Asthenia—Hydrocortisone—ulcerative colitis	0.000718	0.000769	CcSEcCtD
Nafarelin—Anorexia—Prednisone—ulcerative colitis	0.000709	0.00076	CcSEcCtD
Nafarelin—Pruritus—Hydrocortisone—ulcerative colitis	0.000708	0.000758	CcSEcCtD
Nafarelin—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000684	0.000733	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CXCR1—ulcerative colitis	0.000681	0.0113	CbGpPWpGaD
Nafarelin—Urticaria—Betamethasone—ulcerative colitis	0.000679	0.000728	CcSEcCtD
Nafarelin—Urticaria—Dexamethasone—ulcerative colitis	0.000679	0.000728	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000678	0.000727	CcSEcCtD
Nafarelin—Dizziness—Prednisolone—ulcerative colitis	0.000677	0.000726	CcSEcCtD
Nafarelin—Asthenia—Triamcinolone—ulcerative colitis	0.000676	0.000724	CcSEcCtD
Nafarelin—Asthenia—Methylprednisolone—ulcerative colitis	0.000674	0.000723	CcSEcCtD
Nafarelin—Insomnia—Prednisone—ulcerative colitis	0.000673	0.000721	CcSEcCtD
Nafarelin—Paraesthesia—Prednisone—ulcerative colitis	0.000668	0.000716	CcSEcCtD
Nafarelin—Pruritus—Triamcinolone—ulcerative colitis	0.000666	0.000714	CcSEcCtD
Nafarelin—Pruritus—Methylprednisolone—ulcerative colitis	0.000665	0.000713	CcSEcCtD
Nafarelin—Dizziness—Hydrocortisone—ulcerative colitis	0.000661	0.000709	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CCL20—ulcerative colitis	0.000658	0.0109	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—ADRB2—ulcerative colitis	0.000651	0.0108	CbGpPWpGaD
Nafarelin—Decreased appetite—Prednisone—ulcerative colitis	0.000647	0.000693	CcSEcCtD
Nafarelin—Rash—Prednisolone—ulcerative colitis	0.000646	0.000692	CcSEcCtD
Nafarelin—Dermatitis—Prednisolone—ulcerative colitis	0.000645	0.000691	CcSEcCtD
Nafarelin—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000643	0.000689	CcSEcCtD
Nafarelin—Headache—Prednisolone—ulcerative colitis	0.000642	0.000688	CcSEcCtD
Nafarelin—Constipation—Prednisone—ulcerative colitis	0.000636	0.000682	CcSEcCtD
Nafarelin—Vomiting—Hydrocortisone—ulcerative colitis	0.000636	0.000682	CcSEcCtD
Nafarelin—Rash—Hydrocortisone—ulcerative colitis	0.000631	0.000676	CcSEcCtD
Nafarelin—Dermatitis—Hydrocortisone—ulcerative colitis	0.00063	0.000675	CcSEcCtD
Nafarelin—Headache—Hydrocortisone—ulcerative colitis	0.000627	0.000672	CcSEcCtD
Nafarelin—Dizziness—Triamcinolone—ulcerative colitis	0.000623	0.000667	CcSEcCtD
Nafarelin—Dizziness—Methylprednisolone—ulcerative colitis	0.000621	0.000666	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—GNA12—ulcerative colitis	0.000619	0.0103	CbGpPWpGaD
Nafarelin—Asthenia—Dexamethasone—ulcerative colitis	0.000613	0.000657	CcSEcCtD
Nafarelin—Asthenia—Betamethasone—ulcerative colitis	0.000613	0.000657	CcSEcCtD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000611	0.0102	CbGpPWpGaD
Nafarelin—Nausea—Prednisolone—ulcerative colitis	0.000608	0.000652	CcSEcCtD
Nafarelin—Pruritus—Betamethasone—ulcerative colitis	0.000605	0.000648	CcSEcCtD
Nafarelin—Pruritus—Dexamethasone—ulcerative colitis	0.000605	0.000648	CcSEcCtD
Nafarelin—Vomiting—Triamcinolone—ulcerative colitis	0.000599	0.000642	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCL20—ulcerative colitis	0.000597	0.00994	CbGpPWpGaD
Nafarelin—Vomiting—Methylprednisolone—ulcerative colitis	0.000597	0.00064	CcSEcCtD
Nafarelin—Nausea—Hydrocortisone—ulcerative colitis	0.000594	0.000637	CcSEcCtD
Nafarelin—Rash—Triamcinolone—ulcerative colitis	0.000594	0.000636	CcSEcCtD
Nafarelin—Dermatitis—Triamcinolone—ulcerative colitis	0.000593	0.000636	CcSEcCtD
Nafarelin—Rash—Methylprednisolone—ulcerative colitis	0.000592	0.000635	CcSEcCtD
Nafarelin—Dermatitis—Methylprednisolone—ulcerative colitis	0.000592	0.000634	CcSEcCtD
Nafarelin—Urticaria—Prednisone—ulcerative colitis	0.000591	0.000634	CcSEcCtD
Nafarelin—Headache—Triamcinolone—ulcerative colitis	0.00059	0.000632	CcSEcCtD
Nafarelin—Headache—Methylprednisolone—ulcerative colitis	0.000589	0.000631	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000586	0.00976	CbGpPWpGaD
Nafarelin—Diarrhoea—Dexamethasone—ulcerative colitis	0.000585	0.000627	CcSEcCtD
Nafarelin—Diarrhoea—Betamethasone—ulcerative colitis	0.000585	0.000627	CcSEcCtD
Nafarelin—Dizziness—Dexamethasone—ulcerative colitis	0.000565	0.000606	CcSEcCtD
Nafarelin—Dizziness—Betamethasone—ulcerative colitis	0.000565	0.000606	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—GNA12—ulcerative colitis	0.000562	0.00935	CbGpPWpGaD
Nafarelin—Nausea—Triamcinolone—ulcerative colitis	0.000559	0.0006	CcSEcCtD
Nafarelin—Nausea—Methylprednisolone—ulcerative colitis	0.000558	0.000598	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CCR6—ulcerative colitis	0.000551	0.00917	CbGpPWpGaD
Nafarelin—Vomiting—Betamethasone—ulcerative colitis	0.000543	0.000582	CcSEcCtD
Nafarelin—Vomiting—Dexamethasone—ulcerative colitis	0.000543	0.000582	CcSEcCtD
Nafarelin—Rash—Betamethasone—ulcerative colitis	0.000539	0.000577	CcSEcCtD
Nafarelin—Rash—Dexamethasone—ulcerative colitis	0.000539	0.000577	CcSEcCtD
Nafarelin—Dermatitis—Dexamethasone—ulcerative colitis	0.000538	0.000577	CcSEcCtD
Nafarelin—Dermatitis—Betamethasone—ulcerative colitis	0.000538	0.000577	CcSEcCtD
Nafarelin—Headache—Dexamethasone—ulcerative colitis	0.000535	0.000574	CcSEcCtD
Nafarelin—Headache—Betamethasone—ulcerative colitis	0.000535	0.000574	CcSEcCtD
Nafarelin—Asthenia—Prednisone—ulcerative colitis	0.000534	0.000572	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CXCR2—ulcerative colitis	0.000533	0.00886	CbGpPWpGaD
Nafarelin—Pruritus—Prednisone—ulcerative colitis	0.000526	0.000564	CcSEcCtD
Nafarelin—Diarrhoea—Prednisone—ulcerative colitis	0.000509	0.000546	CcSEcCtD
Nafarelin—Nausea—Dexamethasone—ulcerative colitis	0.000508	0.000544	CcSEcCtD
Nafarelin—Nausea—Betamethasone—ulcerative colitis	0.000508	0.000544	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCR6—ulcerative colitis	0.000501	0.00833	CbGpPWpGaD
Nafarelin—Dizziness—Prednisone—ulcerative colitis	0.000492	0.000527	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—SEL1L—ulcerative colitis	0.000488	0.00812	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000485	0.00808	CbGpPWpGaD
Nafarelin—Vomiting—Prednisone—ulcerative colitis	0.000473	0.000507	CcSEcCtD
Nafarelin—Rash—Prednisone—ulcerative colitis	0.000469	0.000503	CcSEcCtD
Nafarelin—Dermatitis—Prednisone—ulcerative colitis	0.000469	0.000502	CcSEcCtD
Nafarelin—Headache—Prednisone—ulcerative colitis	0.000466	0.0005	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—GHRL—ulcerative colitis	0.000444	0.00739	CbGpPWpGaD
Nafarelin—Nausea—Prednisone—ulcerative colitis	0.000442	0.000474	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—PTGER4—ulcerative colitis	0.000441	0.00733	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000413	0.00687	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GHRL—ulcerative colitis	0.000404	0.00671	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCR1—ulcerative colitis	0.000402	0.00669	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CALM3—ulcerative colitis	0.000391	0.0065	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000368	0.00612	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL20—ulcerative colitis	0.000353	0.00587	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ADRB2—ulcerative colitis	0.000334	0.00556	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GNA12—ulcerative colitis	0.000332	0.00552	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCR2—ulcerative colitis	0.000315	0.00523	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCL8—ulcerative colitis	0.000314	0.00523	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000313	0.00521	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000312	0.0052	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR6—ulcerative colitis	0.000296	0.00492	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ADCY5—ulcerative colitis	0.000284	0.00472	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MAML2—ulcerative colitis	0.00028	0.00467	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PTGER4—ulcerative colitis	0.00026	0.00433	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GHRL—ulcerative colitis	0.000238	0.00397	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CALM3—ulcerative colitis	0.000231	0.00384	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RIPK2—ulcerative colitis	0.000227	0.00378	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ADRB2—ulcerative colitis	0.000197	0.00328	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—JAK2—ulcerative colitis	0.000195	0.00324	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000178	0.00296	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—JAK2—ulcerative colitis	0.000177	0.00294	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—IL2—ulcerative colitis	0.00017	0.00283	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ADCY5—ulcerative colitis	0.000168	0.00279	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CXCL8—ulcerative colitis	0.000161	0.00268	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL2—ulcerative colitis	0.000154	0.00257	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—JAK2—ulcerative colitis	0.000104	0.00174	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RELA—ulcerative colitis	0.000101	0.00168	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCL8—ulcerative colitis	9.53e-05	0.00159	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL2—ulcerative colitis	9.11e-05	0.00152	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6—ulcerative colitis	9.06e-05	0.00151	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MMP9—ulcerative colitis	8.62e-05	0.00143	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NFKB1—ulcerative colitis	8.53e-05	0.00142	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—STAT3—ulcerative colitis	7.66e-05	0.00128	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TGFB1—ulcerative colitis	7.1e-05	0.00118	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TP53—ulcerative colitis	5.85e-05	0.000973	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL6—ulcerative colitis	5.35e-05	0.000891	CbGpPWpGaD
